2014
DOI: 10.1186/1742-6405-11-37
|View full text |Cite
|
Sign up to set email alerts
|

Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome

Abstract: IntroductionWe report a case of an adult patient with human immunodeficiency virus (HIV), acute respiratory distress syndrome (ARDS) and ventilator associated pneumonia (VAP) caused by multidrug resistant (MDR) bacteria that was successfully managed with veno-venous extracorporeal membrane oxygenation (ECMO).Case reportA 25 year old male with no significant past medical history had been admitted to a local hospital due to dyspnea and fever. His pulmonary function subsequently failed necessitating mechanical ve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…Several case reports and small series describe the use of ECMO in patients with HIV and respiratory failure. [3][4][5][6][7][8][9][10][11][12][13][14][15] The bias toward reporting successful cases is evident in the 93% survival of the 14 patients reported in these studies. In another study, Capatos et al 16 describe an aggressive approach to the management and cannulation of HIV patients with severe respiratory failure within three institutions in South Africa, with the authors reporting a survival to discharge among their 22 patients of 68% in all patients and 60% in those with Pneumocystis jirovecii pneumonia (PJP).…”
Section: Introductionmentioning
confidence: 99%
“…Several case reports and small series describe the use of ECMO in patients with HIV and respiratory failure. [3][4][5][6][7][8][9][10][11][12][13][14][15] The bias toward reporting successful cases is evident in the 93% survival of the 14 patients reported in these studies. In another study, Capatos et al 16 describe an aggressive approach to the management and cannulation of HIV patients with severe respiratory failure within three institutions in South Africa, with the authors reporting a survival to discharge among their 22 patients of 68% in all patients and 60% in those with Pneumocystis jirovecii pneumonia (PJP).…”
Section: Introductionmentioning
confidence: 99%
“…In the peer-reviewed literature there are a total of ten case descriptions of patients with HIV receiving VV ECMO, with eight survivors. 20,3137 Of note, seven of the cases were for PJP-associated respiratory failure. Most recently, a retrospective series of 22 patients in Africa reported survival to hospital discharge of 68%, and of 60% in the PJP-positive cohort.…”
Section: Discussionmentioning
confidence: 99%
“…The indications for ECMO remain controversial, especially in patients who are immunosuppressed or have non‐recoverable comorbidities. There are several reports of successful ECMO use for severe hypoxia in patients with HIV/AIDS 2, 3, 4, 5, 6, 7, 8, 9, 10. However, key therapeutic issues, such as mechanical ventilation (MV) settings, indications for ECMO, and the timing of antiretroviral therapy (ART), have not always been discussed in these reports.…”
Section: Introductionmentioning
confidence: 99%
“…There are several reports of successful ECMO use for severe hypoxia in patients with HIV/AIDS. [2][3][4][5][6][7][8][9][10] However, key therapeutic issues, such as mechanical ventilation (MV) settings, indications for ECMO, and the timing of antiretroviral therapy (ART), have not always been discussed in these reports. A case of acute respiratory distress syndrome in a patient with novel HIV/ AIDS, who was successfully treated with veno-venous (V-V) ECMO and discharged, is presented.…”
mentioning
confidence: 99%